Side-by-side financials for ENLV and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ENLV | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #47 |
| Net income (latest FY) | $1.24B | - |
| SEC filings | 393 | 1,004 |
Full pages: Enlivex Therapeutics Ltd. and AstraZeneca PLC, or browse the full rankings.